| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8823243 | Journal of the American College of Radiology | 2018 | 8 Pages |
Abstract
Recent changes to screening guidelines for group II gadolinium-based contrast agents by the ACR will likely have major financial implications.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Prasad R. MD, Kushal MD, MBA, Matthew S. MD,